1 Min Read
April 26 (Reuters) - Pharma Mar SA:
* TO PRESENT PRECLINICAL AND CLINICAL RESULTS FROM STUDIES OF THREE MOLECULES FOR TREATMENT OF OPHTHALMOLOGICAL DISORDERS Source text for Eikon: Further company coverage: (Gdynia Newsroom)
All quotes delayed a minimum of 15 minutes. See here for a complete list of exchanges and delays.
© 2018 Reuters. All Rights Reserved.